HER2Know
HER2Know Logo
  • IHC Atlas
  • Supporting Resources
  • IHC Knowledge Check

SUPPORTING RESOURCES

Peer-developed
educational materials


Here you will find a broad range of educational resources to support your HER2 IHC scoring consistency and best practice recommendations from the Pathology Faculty. View the materials, including The significance of HER2 documentary, below.

  1. HER2
  2. Clinical practice support
  3. Clinical practice guidelines

Close Filters Add Filters

Sort by:
Newest to Oldest
  • Newest to Oldest
Filters:
Results

Search Results

View more

MICROSCOPY SERIES

Microscopy review:
Slide validation

Dr. Bui discusses specimen requirements and recommendations to reduce pre-analytical variables. (17 mins)

Play video

MICROSCOPY SERIES

Microscopy review:
Approaching the scoring

Dr. Tozbikian demonstrates current approaches to HER2 IHC scoring. (17 mins)

Play video

MICROSCOPY SERIES

Microscopy review: Areas of diagnostic pitfalls

Dr. Hicks highlights considerations when interpreting HER2 status. (19 mins)

Play video

MICROSCOPY SERIES

Microscopy review: Correlating interpretation with clinical history

Dr. Feldman discusses histopathologic findings in view of the clinical background. (15 mins)

Play video

E-LEARNING

From past to present: The significance of HER2 in breast cancer

In the first session of this three-part program, Dr. Wei explores the spectrum of HER2 expression with slide reviews from Dr. Krishnamurthy and Dr. Wen. (48 mins)

Play video

E-LEARNING

Consistency with practice: Standardizing the approach to HER2 IHC scoring

Dr. Hicks discusses the importance of pre-analytic, analytic, and post-analytic variables. Dr. Khoury and Dr. Tozbikian review artifacts and indeterminate staining patterns. (57 mins) 

Play video

E-LEARNING

Challenge accepted: Best practices for scoring HER2 across the spectrum

Dr. Jaffer provides guidance on recognition of HER2 staining patterns and heterogeneity. Dr. Krishnamurthy and Dr. Bui present challenging HER2 IHC cases. (60 mins)

Play video

E-LEARNING

Interpreting HER2 in breast cancer: USCAP course summary

Summary documents of the USCAP e-learning program Interpreting HER2 in breast cancer: A full spectrum of possibilities.

MY-15056

Download

DOCUMENTARY

The significance of HER2: Trailer

A short preview of a mini documentary-style film presented by Dr. Marilyn Bui and Dr. Hope S. Rugo. (2 mins)

Play video

DOCUMENTARY

The significance of HER2

Dr. Marilyn Bui, pathologist, and Dr. Hope S. Rugo, oncologist, discuss the evolution of HER2 as a breast cancer biomarker in this mini documentary-style film. (19 mins)

Play video

ANIMATION

Lives behind slides

This short animation depicts patients with breast cancer, whose lives are impacted by their HER2 status. (2 mins)

Play video

ANIMATION

Recognizing HER2 staining patterns at the low end of the spectrum

A short animation, discussing best practice recommendations for scoring HER2 by IHC with Dr. Feldman. (4 mins)

Play video

E-LEARNING

Topic 1: Clinical innovation across the HER2 pathway

Dr. Krishnamurthy presents the evolution of HER2 in clinical practice. (7 mins)

Play video

E-LEARNING

Topic 2: The spectrum of HER2 expression

Dr. Tozbikian reviews current HER2 guidelines and the significance of discrete HER2 IHC scoring. (9 mins)

Play video

E-LEARNING

Topic 3: Overcoming challenges in assessing HER2 expression across the spectrum

Dr. Hicks highlights best clinical practices for differentiating low levels of HER2. (11 mins)

Play video

MICROSCOPY SERIES

Microscopy review:
Slide validation

Dr. Bui discusses specimen requirements and recommendations to reduce pre-analytical variables. (17 mins)

Play video

MICROSCOPY SERIES

Microscopy review:
Approaching the scoring

Dr. Tozbikian demonstrates current approaches to HER2 IHC scoring. (17 mins)

Play video

MICROSCOPY SERIES

Microscopy review: Areas of diagnostic pitfalls

Dr. Hicks highlights considerations when interpreting HER2 status. (19 mins)

Play video

MICROSCOPY SERIES

Microscopy review: Correlating interpretation with clinical history

Dr. Feldman discusses histopathologic findings in view of the clinical background. (15 mins)

Play video

E-LEARNING

From past to present: The significance of HER2 in breast cancer

In the first session of this three-part program, Dr. Wei explores the spectrum of HER2 expression with slide reviews from Dr. Krishnamurthy and Dr. Wen. (48 mins)

Play video

E-LEARNING

Consistency with practice: Standardizing the approach to HER2 IHC scoring

Dr. Hicks discusses the importance of pre-analytic, analytic, and post-analytic variables. Dr. Khoury and Dr. Tozbikian review artifacts and indeterminate staining patterns. (57 mins) 

Play video

E-LEARNING

Challenge accepted: Best practices for scoring HER2 across the spectrum

Dr. Jaffer provides guidance on recognition of HER2 staining patterns and heterogeneity. Dr. Krishnamurthy and Dr. Bui present challenging HER2 IHC cases. (60 mins)

Play video

E-LEARNING

Interpreting HER2 in breast cancer: USCAP course summary

Summary documents of the USCAP e-learning program Interpreting HER2 in breast cancer: A full spectrum of possibilities.

MY-15056

Download

DOCUMENTARY

The significance of HER2: Trailer

A short preview of a mini documentary-style film presented by Dr. Marilyn Bui and Dr. Hope S. Rugo. (2 mins)

Play video

DOCUMENTARY

The significance of HER2

Dr. Marilyn Bui, pathologist, and Dr. Hope S. Rugo, oncologist, discuss the evolution of HER2 as a breast cancer biomarker in this mini documentary-style film. (19 mins)

Play video

ANIMATION

Lives behind slides

This short animation depicts patients with breast cancer, whose lives are impacted by their HER2 status. (2 mins)

Play video

ANIMATION

Recognizing HER2 staining patterns at the low end of the spectrum

A short animation, discussing best practice recommendations for scoring HER2 by IHC with Dr. Feldman. (4 mins)

Play video

E-LEARNING

Topic 1: Clinical innovation across the HER2 pathway

Dr. Krishnamurthy presents the evolution of HER2 in clinical practice. (7 mins)

Play video

E-LEARNING

Topic 2: The spectrum of HER2 expression

Dr. Tozbikian reviews current HER2 guidelines and the significance of discrete HER2 IHC scoring. (9 mins)

Play video

E-LEARNING

Topic 3: Overcoming challenges in assessing HER2 expression across the spectrum

Dr. Hicks highlights best clinical practices for differentiating low levels of HER2. (11 mins)

Play video
  1. Teaser 1
  2. Teaser 2
  3. Teaser 3
  4. Teaser 4
  5. Teaser 5
  6. Teaser 6
  7. Teaser 7
  8. Teaser 8
  9. Teaser 9
  10. Teaser 10
  11. Teaser 11
  12. Teaser 12
  13. Teaser 13
  14. Teaser 14
  15. Teaser 15
  1. Teaser 1
  2. Teaser 2
  3. Teaser 3
  4. Teaser 4
  5. Teaser 5
  6. Teaser 6
  7. Teaser 7
  8. Teaser 8
  9. Teaser 9
  10. Teaser 10
  11. Teaser 11
  12. Teaser 12
  13. Teaser 13
  14. Teaser 14
  15. Teaser 15

WEBINAR

Pathology in practice: The breast HER2 spectrum

A webinar hosted by the CAP Foundation highlighting the evolution of practice guidelines for HER2 testing in breast cancer. (50 mins)

Play video

MICROSCOPY SERIES

Microscopy review:
Slide validation

Dr. Bui discusses specimen requirements and recommendations to reduce pre-analytical variables. (17 mins)

Play video

MICROSCOPY SERIES

Microscopy review:
Approaching the scoring

Dr. Tozbikian demonstrates current approaches to HER2 IHC scoring. (17 mins)

Play video

MICROSCOPY SERIES

Microscopy review: Areas of diagnostic pitfalls

Dr. Hicks highlights considerations when interpreting HER2 status. (19 mins)

Play video

MICROSCOPY SERIES

Microscopy review: Correlating interpretation with clinical history

Dr. Feldman discusses histopathologic findings in view of the clinical background. (15 mins)

Play video

E-LEARNING

From past to present: The significance of HER2 in breast cancer

In the first session of this three-part program, Dr. Wei explores the spectrum of HER2 expression with slide reviews from Dr. Krishnamurthy and Dr. Wen. (48 mins)

Play video

E-LEARNING

Consistency with practice: Standardizing the approach to HER2 IHC scoring

Dr. Hicks discusses the importance of pre-analytic, analytic, and post-analytic variables. Dr. Khoury and Dr. Tozbikian review artifacts and indeterminate staining patterns. (57 mins) 

Play video

E-LEARNING

Challenge accepted: Best practices for scoring HER2 across the spectrum

Dr. Jaffer provides guidance on recognition of HER2 staining patterns and heterogeneity. Dr. Krishnamurthy and Dr. Bui present challenging HER2 IHC cases. (60 mins)

Play video

E-LEARNING

Interpreting HER2 in breast cancer: USCAP course summary

Summary documents of the USCAP e-learning program Interpreting HER2 in breast cancer: A full spectrum of possibilities.

MY-15056

Download

ALGORITHM

Algorithmic approach to standardizing HER2 scoring

Dr. Hicks shares his approach for scoring HER2 by IHC.

MY-15058

Download

GUIDE

HER2 IHC scoring resource and guide

A summarized approach to HER2 IHC interpretation, based on most recent guidelines and expert opinion.

MY-15055

Download

GUIDE

HER2 differentiation in practice: a quick visual guide

An in-lab visual reference for recognizing HER2 IHC staining patterns to assist clinical practice.

MY-15057

Download

GUIDE

HER2 expression in breast cancer: A comprehensive reference

A downloadable comprehensive guide to HER2 IHC scoring.

MY-15055

Download

ANIMATION

Recognizing HER2 staining patterns at the low end of the spectrum

A short animation, discussing best practice recommendations for scoring HER2 by IHC with Dr. Feldman. (4 mins)

Play video

WEBINAR

Pathology in practice: The breast HER2 spectrum

A webinar hosted by the CAP Foundation highlighting the evolution of practice guidelines for HER2 testing in breast cancer. (50 mins)

Play video

MICROSCOPY SERIES

Microscopy review:
Slide validation

Dr. Bui discusses specimen requirements and recommendations to reduce pre-analytical variables. (17 mins)

Play video

MICROSCOPY SERIES

Microscopy review:
Approaching the scoring

Dr. Tozbikian demonstrates current approaches to HER2 IHC scoring. (17 mins)

Play video

MICROSCOPY SERIES

Microscopy review: Areas of diagnostic pitfalls

Dr. Hicks highlights considerations when interpreting HER2 status. (19 mins)

Play video

MICROSCOPY SERIES

Microscopy review: Correlating interpretation with clinical history

Dr. Feldman discusses histopathologic findings in view of the clinical background. (15 mins)

Play video

E-LEARNING

From past to present: The significance of HER2 in breast cancer

In the first session of this three-part program, Dr. Wei explores the spectrum of HER2 expression with slide reviews from Dr. Krishnamurthy and Dr. Wen. (48 mins)

Play video

E-LEARNING

Consistency with practice: Standardizing the approach to HER2 IHC scoring

Dr. Hicks discusses the importance of pre-analytic, analytic, and post-analytic variables. Dr. Khoury and Dr. Tozbikian review artifacts and indeterminate staining patterns. (57 mins) 

Play video

E-LEARNING

Challenge accepted: Best practices for scoring HER2 across the spectrum

Dr. Jaffer provides guidance on recognition of HER2 staining patterns and heterogeneity. Dr. Krishnamurthy and Dr. Bui present challenging HER2 IHC cases. (60 mins)

Play video

E-LEARNING

Interpreting HER2 in breast cancer: USCAP course summary

Summary documents of the USCAP e-learning program Interpreting HER2 in breast cancer: A full spectrum of possibilities.

MY-15056

Download

ALGORITHM

Algorithmic approach to standardizing HER2 scoring

Dr. Hicks shares his approach for scoring HER2 by IHC.

MY-15058

Download

GUIDE

HER2 IHC scoring resource and guide

A summarized approach to HER2 IHC interpretation, based on most recent guidelines and expert opinion.

MY-15055

Download

GUIDE

HER2 differentiation in practice: a quick visual guide

An in-lab visual reference for recognizing HER2 IHC staining patterns to assist clinical practice.

MY-15057

Download

GUIDE

HER2 expression in breast cancer: A comprehensive reference

A downloadable comprehensive guide to HER2 IHC scoring.

MY-15055

Download

ANIMATION

Recognizing HER2 staining patterns at the low end of the spectrum

A short animation, discussing best practice recommendations for scoring HER2 by IHC with Dr. Feldman. (4 mins)

Play video
  1. Teaser 16
  2. Teaser 1
  3. Teaser 2
  4. Teaser 3
  5. Teaser 4
  6. Teaser 5
  7. Teaser 6
  8. Teaser 7
  9. Teaser 8
  10. Teaser 10
  11. Teaser 11
  12. Teaser 12
  13. Teaser 13
  14. Teaser 9
  1. Teaser 16
  2. Teaser 1
  3. Teaser 2
  4. Teaser 3
  5. Teaser 4
  6. Teaser 5
  7. Teaser 6
  8. Teaser 7
  9. Teaser 8
  10. Teaser 10
  11. Teaser 11
  12. Teaser 12
  13. Teaser 13
  14. Teaser 9

Close Filters Add Filters

Sort by:
Newest to Oldest
  • Newest to Oldest
Filters:
Results

Search Results

View more

GUIDELINES

CAP quantitative image analysis (QIA) guidelines

Recommendations for optimizing interpretation of HER2 IHC performed by QIA in breast cancer.

View guidelines

GUIDELINES

The most recent ASCO/CAP HER2 testing guidelines

Recommendations for improving accuracy and standardization of HER2 testing in breast cancer.

View guidelines

GUIDELINES

CAP quantitative image analysis (QIA) guidelines

Recommendations for optimizing interpretation of HER2 IHC performed by QIA in breast cancer.

View guidelines

GUIDELINES

The most recent ASCO/CAP HER2 testing guidelines

Recommendations for improving accuracy and standardization of HER2 testing in breast cancer.

View guidelines
  1. Teaser2
  2. Teaser1
  1. Teaser2
  2. Teaser1

Close Filters Add Filters

Sort by:
Newest to Oldest
  • Newest to Oldest
Filters:
Results

Search Results

View more

CAP, College of American Pathologists; HER2, human epidermal growth factor receptor 2; IHC, immunohistochemistry; USCAP, United States and Canadian Academy of Pathology.

HER2Know Logo

Request an AstraZeneca Medical Affairs Representative Follow-Up

Microscopy review: Slide validation

Dr. Bui discusses specimen requirements and recommendations to reduce pre-analytical variables. (17 mins) 

MY-15063

Microscopy review: Approaching the scoring

Dr. Tozbikian demonstrates current approaches to HER2 IHC scoring. (17 mins)

MY-13529

Microscopy review: Areas of diagnostic pitfalls

Dr. Hicks highlights considerations when interpreting HER2 status. (19 mins)

MY-15061

Recognizing HER2 staining patterns at the low end of the spectrum

A short animation, discussing best practice recommendations for scoring HER2 by IHC with Dr. Feldman. (4 mins)

MY-15062

Topic 1: Clinical innovation across the HER2 pathway

Dr. Krishnamurthy presents the evolution of HER2 in clinical practice. (7 mins)

MY-13516

Topic 2: The spectrum of HER2 expression

Dr. Tozbikian reviews current HER2 guidelines and the significance of discrete HER2 IHC scoring. (9 mins)

MY-13526

Topic 3: Overcoming challenges in assessing HER2 expression across the spectrum

Dr. Hicks highlights best clinical practices for differentiating low levels of HER2. (11 mins)

MY-15053

Pathology in practice: The breast HER2 spectrum

A webinar hosted by the CAP Foundation highlighting the evolution of practice guidelines for HER2 testing in breast cancer. (50 mins)

Microscopy review: Slide validation

Dr. Bui discusses specimen requirements and recommendations to reduce pre-analytical variables. (17 mins) 

MY-15063

Her2know Logo

Quick links

  • IHC Atlas
  • Supporting Resources
  • IHC Knowledge Check

About us

  • Contact Us
  • Request Medical Follow-Up
  • AstraZeneca

Legal

  • Privacy Notice
  • Cookie Policy
  • Legal Notices and Terms of Uses
Daiichi Logo

©2023 Daiichi Sankyo, Inc. and AstraZeneca
US-77216, PP-US-8201a-1686 07/23

Microscopy review: Correlating interpretation with clinical history 

Dr. Feldman discusses histopathologic findings in view of the clinical background. (15 mins)

MY-15060

From past to present: The significance of HER2 in breast cancer

Dr. Jaffer provides guidance on recognition of HER2 staining patterns and heterogeneity. Dr. Krishnamurthy and Dr. Bui present challenging HER2 IHC cases. (60 mins)

Consistency with practice: Standardizing the approach to HER2 IHC scoring

Dr. Hicks discusses the importance of pre-analytic, analytic, and post-analytic variables. Dr. Khoury and Dr. Tozbikian review artifacts and indeterminate staining patterns. (57 mins)

Challenge accepted: Best practices for scoring HER2 across the spectrum

Dr. Jaffer provides guidance on recognition of HER2 staining patterns and heterogeneity. Dr. Krishnamurthy and Dr. Bui present challenging HER2 IHC cases. (60 mins)

The significance of HER2: Trailer

A short preview of a mini documentary-style film presented by Dr. Marilyn Bui and Dr. Hope S. Rugo. (2 mins)

MY-13515

The significance of HER2

Dr. Marilyn Bui, pathologist, and Dr. Hope S. Rugo, oncologist, discuss the evolution of HER2 as a breast cancer biomarker in this mini documentary-style film. (19 mins)

MY-15054

Lives behind slides

This short animation depicts patients with breast cancer, whose lives are impacted by their HER2 status. (2 mins)

MY-13528

Welcome to HER2Know

This website is intended to help healthcare professionals practicing in Malaysia. find and access scientifically balanced, evidence-based, and peer-led information and professional resources in support of HER2 IHC evaluation in breast cancer.

The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This information is provided for educational purposes only. It is not intended for use in the diagnosis or treatment of individual patients.

Are you a healthcare professional practicing in Malaysia?

I am an AstraZeneca or Daiichi Sankyo Company authorized person

What is an AstraZeneca or Daiichi Sankyo Company authorized person?

This website is only intended for healthcare professionals practicing in Malaysia and authorized AstraZeneca or Daiichi Sankyo Company person. Malaysia Headquarters personnel and Malaysia Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. This website is not intended for use by Malaysia Field Sales personnel. None of the content of this site should be directly linked or distributed without approval.

Self Certification Buttons
No, take me to AstraZeneca.com Self Certification Buttons